Martijn Arns, PhD

Martijn Arns is an applied neuroscientist and entrepreneur with a strong background in brain stimulation, BCI/neurofeedback and medtech. Martijn is founder and director at Brainclinics Foundationand is a visiting scholar at Stanford University (Stanford Brain Stimulation Lab & Psychedelics and Consciousness Lab) and thus 'in between places': Nijmegen (Netherlands) and Palo Alto (US).

In 2001, Martijn founded Research Institute Brainclinics (part of the non-profit Brainclinics Foundation). The Brainclinics Foundation’s primary mission is best summarized as: Applied Neuroscience from the clinic, to the clinic and focuses on interventional psychiatry and applied neuroscience where research outcomes should be easily translatable into clinical practice and clinically actionable. Martijn's expertise extends to the development and application of brain stimulation techniques, such as rTMS for depression and OCD, TMS induced Heart-Brain Coupling, Neurofeedback/Brain Computer Interfaces (BCI), Psychedelics as a novel intervention and EEG based precision psychiatry and stratified psychiatry.

Martijn published over 190 scientific papers and four patents. Throughout his career, he has successfully established several spin-off ventures from Brainclinics. These include Brainquiry (founded in 2002), which introduced the first portable Bluetooth-based EEG system and a smartwatch (years before the Apple Watch), neurocare group (established in 2015), an international innovative mental health clinic specialised in TMS and neurofeedback, neurocademy (launched in 2015), a training platform for certification in neuromodulation treatments (TMS and neurofeedback), and in 2023 spun-out the Brainmarker platform, an EEG based platform used for treatment stratification. In 2007 he was awarded the FD Gazellen award for fastest growing company.

Martijn's contributions to the scientific community extend beyond his research and spin-offs. He has served as an (associate) editor for various scientific journals and books. Moreover, he organized numerous international conferences and served on the boards of several (inter)national professional non-profit organizations. As scientific advisor, he has lent his expertise to several medtech and AI start-ups as well as established companies, contributing to advancements and implementation in the field.